InvestorsHub Logo
Followers 54
Posts 4438
Boards Moderated 0
Alias Born 08/21/2015

Re: PennyTrader2017 post# 17968

Monday, 03/27/2017 7:21:43 AM

Monday, March 27, 2017 7:21:43 AM

Post# of 74527
Otiko pays Phillips Company. Phillips doesnt pay Otiko. Phillips Company owns the products Otiko is trying to sell in a competitive market. Otiko has one non-exclusive manufacturing license for Viabecline, which essentially is the same product as Diabecline--Pharmacline's 2012 Edison Award Winner. It is manufactured at Phillips' facility in Oklahoma.

Otiko has non-exclusive distribution agreements for other Phillips products.

Keough (aka Pharmacline/Thru Pharma/Dakota Life Sciences) doesnt steal IP. He acquires IP. Here is a summary of his experience.

Mr. Keough is a graduate of Boston College Law School (J.D.), the Catholic University of America in Washington, D.C. (M.A. in Congressional Studies), and the United States Naval Academy at Annapolis (B.S.). His technology area of physics and his background as a submarine officer enable him to navigate comfortably in most technology fields, including medical devices and related sciences, manufacturing, optics, computer science, chemical coatings, formulations, and numerous others.

In the late 1980s, Mr. Keough was responsible for the patent accounts of numerous Asia-based manufacturing giants. He then went on to become widely known in the 1990s as an international expert on the phenomenon known as patent flooding. Mr. Keough played a pivotal role in the corporate-legal relationship of the mid-2000s which led to the largest medical device product release in history. This involved the first drug eluting cardiac stent to reach the United States market. From 2004-2008, Mr. Keough was Chief Patent Counsel at a public company, and contributed to the rapid rise of that company's market valution during his tenure.

With decades of experience in private practice and corporate settings, Mr. Keough has great insight into product life cycles and strategies of protection. He received a certificate in Finance for Non-Financial Executives from the Graduate School of the University of Chicago, and is quite aware of the financial pressures on corporate budgets. This awareness is at the heart of his founding of Law Offices National, P.A., to provide highly focused and efficient service in the patent arena- which has been a very costly area of patent expense to most businesses.

As a naval officer, Mr. Keough specialized in missile technology. He also commanded numerous U. S. naval forces in virtually all of the geographic regions of the world- retiring in 2004 at the naval rank of Captain. Mr. Keough also served as a Congressionally appointed civilian panel member charged with overseeing the conduct of the U.S. Department of Defense Threat Reduction Agency in the late 1990s and early 2000s. His area of responsibility related specifically to mitigating threats against the country from nuclear devices.



http://www.lawoffnat.com/home/about-us/founder-steve-keough